ARCHIVES

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

In Brief: James Downing named CEO of St. Jude

June 27, 2014

Breast Implants Lessen Ability Of Mammograms To Find Cancer

February 27, 2004

Four Patients In Tamoxifin Treatment Trial Had Died of Uterine Cancer Prior To BCPT

April 29, 1994

Bishop: Cells, Genes Reveal Unified Strategy For Cancer Conquest

March 3, 1995

DRCCA Board Okays Concepts Of New Cooperative Agreements For Smoking Program, Flow Cytometry For Bladder Cancer

October 28, 1983